Covid-19 a triggering factor of autoimmune and multi-inflammatory diseases

Tools

Sher, E.K., Ćosović, A., Džidić-Krivić, A., Farhat, E.K., Pinjić, E. and Sher, F. ORCID: 0000-0003-2890-5912, 2023. Covid-19 a triggering factor of autoimmune and multi-inflammatory diseases. Life Sciences, 319: 121531. ISSN 0024-3205

Full text not available from this repository.

Official URL: https://doi.org/10.1016/j.lfs.2023.121531

Abstract

SARS-CoV-2 virus has attracted a lot of attention globally due to the autoimmune and inflammatory processes that were observed during the development of Covid-19 disease. Excessive activation of immune response and triggering of autoantibodies synthesis as well as an excessive synthesis of inflammatory cytokines and the onset of cytokine storm has a vital role in the disease outcome and the occurring autoimmune complications. This scenario is reminiscent of infiltration of lymphocytes and monocytes in specific organs and the increased production of autoantibodies and chemoattractants noted in other inflammatory and autoimmune diseases. The main goal of this study is to investigate the complex inflammatory processes that occur in Covid-19 disease and to find similarities with other inflammatory diseases such as multiple sclerosis (MS), acute respiratory distress syndrome (ARDS), rheumatoid arthritis (RA) and Kawasaki syndrome to advance existing diagnostic and therapeutic protocols. The therapy with Interferon-gamma (IFN-γ) and the use of S1P receptor modulators showed promising results. However, there are many unknowns about these mechanisms and possible novel therapies. Therefore, the inflammation and autoimmunity triggered by Covid-19 should be further investigated to improve existing diagnostic procedures and therapeutic protocols for Covid-19.

Item Type:

Journal article

Publication Title:

Life Sciences

Creators:

Sher, E.K., Ćosović, A., Džidić-Krivić, A., Farhat, E.K., Pinjić, E. and Sher, F.

Publisher:

Elsevier

Date:

April 2023

Volume:

319